|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-5-6
|
|
pubmed:abstractText |
Serum levels of the soluble receptor for advanced glycation end-products (sRAGE) have been associated with risk of cardiovascular disease. We hypothesized that sRAGE levels are associated with subclinical cerebrovascular disease in an ethnically diverse population.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1879-1484
|
|
pubmed:author |
pubmed-author:DeCarliCharlesC,
pubmed-author:ElkindMitchell S VMS,
pubmed-author:HudsonBarry IBI,
pubmed-author:KaleaAnastasia ZAZ,
pubmed-author:KhatriMineshM,
pubmed-author:MarquezChensyC,
pubmed-author:MoonYeseon ParkYP,
pubmed-author:PaikMyunghee CMC,
pubmed-author:SaccoRalph LRL,
pubmed-author:SchmidtAnn MarieAM,
pubmed-author:WrightClinton BCB,
pubmed-author:YoshitaMitsuhiroM
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
216
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
192-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21316677-African Americans,
pubmed-meshheading:21316677-Aged,
pubmed-meshheading:21316677-Asymptomatic Diseases,
pubmed-meshheading:21316677-Biological Markers,
pubmed-meshheading:21316677-Brain,
pubmed-meshheading:21316677-Cerebrovascular Disorders,
pubmed-meshheading:21316677-Down-Regulation,
pubmed-meshheading:21316677-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21316677-Ethnic Groups,
pubmed-meshheading:21316677-European Continental Ancestry Group,
pubmed-meshheading:21316677-Female,
pubmed-meshheading:21316677-Hispanic Americans,
pubmed-meshheading:21316677-Humans,
pubmed-meshheading:21316677-Linear Models,
pubmed-meshheading:21316677-Logistic Models,
pubmed-meshheading:21316677-Magnetic Resonance Imaging,
pubmed-meshheading:21316677-Male,
pubmed-meshheading:21316677-New York City,
pubmed-meshheading:21316677-Odds Ratio,
pubmed-meshheading:21316677-Prevalence,
pubmed-meshheading:21316677-Receptors, Immunologic,
pubmed-meshheading:21316677-Risk Assessment,
pubmed-meshheading:21316677-Risk Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).
|
|
pubmed:affiliation |
Division of Surgical Science, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA. bhudson@med.miami.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
